Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease
DAIC
FEBRUARY 13, 2024
Image courtesy: Cleerly christine.book Tue, 02/13/2024 - 11:47 February 13, 2024 — Cleerly , a digital healthcare company focused on artificial intelligence (AI)-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan.
Let's personalize your content